TY - JOUR
T1 - Characteristic clinical features of adipsic hypernatremia patients with subfornical organ-targeting antibody
AU - Nakamura-Utsunomiya, Akari
AU - Hiyama, Takeshi Y.
AU - Okada, Satoshi
AU - Noda, Masaharu
AU - Kobayashi, Masao
N1 - Funding Information:
This work was supported by the Japanese Society for Pediatric Endocrinology Future Development Grant sponsored by Novo Nordisk Pharma, Ltd. We are grateful to Drs. Eiji Watanabe, Masahito Matsumoto, Akihiro Fujikawa, and Lin Chia-Hao (NIBB) for their analyses. We are also grateful to Shinichi Matsuda, Hiroshi Kajiwara, and Fumio Niimura (Tokai University School of Medicine); Drs. Keiichi Hara (Kure Medical Center), Reiko Kagawa, and Sonoko Sakata (Hiroshima University Hospital), Mayumi Ishikawa, Hideo Cho, and
Publisher Copyright:
© 2017 by The Japanese Society for Pediatric Endocrinology.
PY - 2017
Y1 - 2017
N2 - Adipsic hypernatremia is a rare disease presenting as persistent hypernatremia with disturbance of thirst regulation and hypothalamic dysfunction. As a result of congenital disease, tumors, or inflammation, most cases are accompanied by structural abnormalities in the hypothalamicpituitary area. While cases with no hypothalamic-pituitary structural lesion have been reported, their etiology has not been elucidated. Recently, we reported three patients with adipsic hypernatremia whose serum-derived immunoglobulin (Ig) specifically reacted with mouse subfornical organ (SFO) tissue. As one of the circumventricular organs (CVOs) that form a sensory interface between the blood and brain, the SFO is a critical site for generating physiological responses to dehydration and hypernatremia. Intravenous injection of the patient’s Ig fraction induced hypernatremia in mice, along with inflammation and apoptosis in the SFO. These results support a new autoimmunityrelated mechanism for inducing adipsic hypernatremia without demonstrable hypothalamic-pituitary structural lesions. In this review, we aim to highlight the characteristic clinical features of these patients, in addition to etiological mechanisms related to SFO function. These findings may be useful for diagnosing adipsic hypernatremia caused by an autoimmune response to the SFO, and support development of new strategies for prevention and treatment.
AB - Adipsic hypernatremia is a rare disease presenting as persistent hypernatremia with disturbance of thirst regulation and hypothalamic dysfunction. As a result of congenital disease, tumors, or inflammation, most cases are accompanied by structural abnormalities in the hypothalamicpituitary area. While cases with no hypothalamic-pituitary structural lesion have been reported, their etiology has not been elucidated. Recently, we reported three patients with adipsic hypernatremia whose serum-derived immunoglobulin (Ig) specifically reacted with mouse subfornical organ (SFO) tissue. As one of the circumventricular organs (CVOs) that form a sensory interface between the blood and brain, the SFO is a critical site for generating physiological responses to dehydration and hypernatremia. Intravenous injection of the patient’s Ig fraction induced hypernatremia in mice, along with inflammation and apoptosis in the SFO. These results support a new autoimmunityrelated mechanism for inducing adipsic hypernatremia without demonstrable hypothalamic-pituitary structural lesions. In this review, we aim to highlight the characteristic clinical features of these patients, in addition to etiological mechanisms related to SFO function. These findings may be useful for diagnosing adipsic hypernatremia caused by an autoimmune response to the SFO, and support development of new strategies for prevention and treatment.
KW - Adipsic hypernatremia
KW - Hypothalamus dysfunction
KW - Sensory circumventricular organs
KW - Subfornical organ
UR - http://www.scopus.com/inward/record.url?scp=85030224399&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85030224399&partnerID=8YFLogxK
U2 - 10.1297/cpe.26.197
DO - 10.1297/cpe.26.197
M3 - Review article
AN - SCOPUS:85030224399
SN - 0918-5739
VL - 26
SP - 197
EP - 205
JO - Clinical Pediatric Endocrinology
JF - Clinical Pediatric Endocrinology
IS - 4
ER -